competing in the networked economy : Speakers
Arthur Holden joined Illumina in April 2006. He leads development of relationships and partnerships with pharmaceutical firms, large-scale research consortia, and governmental bodies such as the NIH and FDA. Mr. Holden was most recently chairman and CEO of First Genetic Trust and the company's principal founder. He serves as chairman of the Pharmaceutical Biomedical Research Consortium and the DMD Translational Research Consortium
Holden was formerly CEO of the SNP Consortium, Ltd. and CEO and a director of Celsis International, PLC, an industrial biotechnology company. Prior to Celsis, Mr. Holden spent the majority of his career as an executive at Baxter International. Arthur Holden serves on a number of commercial and non-profit boards. He earned his MBA from Northwestern University's Kellogg School of Management (Chicago, IL) and a BS from Union College (Schenectady, NY).

